Photo taken from Mark Storey/Twitter
Dec 3, 2023, 16:14
Mark Storey: From asymptomatic to oligo, we remain a critical component of treatment
Mark Storey, Radiation Oncologist at the Oklahoma Proton Center, shared on X/Twitter:
“Today’s article looks at radiation in the metastatic setting – Four trials from 2023. Two with OS benefit (while SABR-COMET sits in backdrop). From asymptomatic to oligo, we remain a critical component of treatment.”
Source: Mark Storey/Twitter
Jul 26, 2024, 08:02